Repro Med Correlations
KRMD Stock | USD 2.81 0.14 4.75% |
The current 90-days correlation between Repro Med Systems and Precision Optics, is -0.03 (i.e., Good diversification). The correlation of Repro Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Repro Med Correlation With Market
Weak diversification
The correlation between Repro Med Systems and DJI is 0.39 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Repro Med Systems and DJI in the same portfolio, assuming nothing else is changed.
Repro |
Moving together with Repro Stock
0.69 | VOR | Vor Biopharma | PairCorr |
0.63 | CAT | Caterpillar | PairCorr |
0.7 | BA | Boeing | PairCorr |
0.88 | AXP | American Express Sell-off Trend | PairCorr |
0.73 | HPQ | HP Inc | PairCorr |
0.64 | JPM | JPMorgan Chase | PairCorr |
0.71 | DIS | Walt Disney | PairCorr |
0.73 | WMT | Walmart Aggressive Push | PairCorr |
Moving against Repro Stock
0.77 | CMRX | Chimerix | PairCorr |
0.7 | VZ | Verizon Communications | PairCorr |
0.6 | JNJ | Johnson Johnson | PairCorr |
0.51 | T | ATT Inc Earnings Call This Week | PairCorr |
0.47 | BKLRF | Berkeley Energy | PairCorr |
0.46 | MCD | McDonalds | PairCorr |
0.42 | XOM | Exxon Mobil Corp Aggressive Push | PairCorr |
0.4 | INTC | Intel | PairCorr |
0.33 | CVX | Chevron Corp Sell-off Trend | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Repro Stock performing well and Repro Med Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Repro Med's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
POCI | 2.26 | (0.05) | 0.00 | (0.17) | 0.00 | 4.44 | 13.51 | |||
INFU | 2.53 | (0.47) | 0.00 | (0.34) | 0.00 | 4.40 | 19.13 | |||
UTMD | 0.65 | (0.12) | 0.00 | (0.35) | 0.00 | 1.10 | 4.92 | |||
MLSS | 4.01 | 0.53 | 0.10 | 0.57 | 4.79 | 7.63 | 37.01 | |||
MMSI | 1.22 | 0.05 | 0.00 | (0.01) | 0.00 | 2.91 | 7.42 | |||
ATRC | 2.14 | 0.20 | 0.06 | 0.10 | 3.02 | 4.56 | 16.13 | |||
BDXB | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
PDEX | 3.75 | 0.17 | 0.04 | 0.16 | 4.22 | 8.67 | 34.56 | |||
ATRI | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Repro Med Corporate Management
Brian Case | Chief Officer | Profile | |
Thomas Adams | Chief Officer | Profile | |
Rob Cannon | Vice Sales | Profile | |
Josh Bennett | VP Devel | Profile | |
Kenneth Miller | Chief Officer | Profile | |
Tom Adams | Interim Officer | Profile |